Ex Vivo Drug Sensitivity Testing and Multi-Omics Profiling

Clinical trial NCT05857969 · RECRUITING

Trial details

NCT number: NCT05857969
Sponsor: Florida International University
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Recurrent Childhood Acute Myeloid Leukemia Recurrent Childhood Acute Lymphoblastic Leukemia Recurrent Childhood Large Cell Lymphoma Refractory Childhood Acute Lymphoblastic Leukemia Refractory Childhood Hodgkin Lymphoma Refractory Childhood Malignant Germ Cell Neoplasm Recurrent Childhood Brain Tumor Recurrent Childhood Brainstem Glioma Recurrent Childhood Rhabdomyosarcoma Recurrent Childhood Soft Tissue Sarcoma Recurrent Childhood Ependymoma Recurrent Childhood Lymphoblastic Lymphoma

Start date: 2023-02-22
Primary completion: 2028-02-22
Enrollment: 65

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.